|
1
|
Nasim F, Sabath BF and Eapen GA: Lung
cancer. Med Clin North Am. 103:463–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duma N, Santana-Davila R and Molina JR:
Non-small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoy H, Lynch T and Beck M: Surgical
treatment of lung cancer. Crit Care Nurs Clin North Am. 31:303–313.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Skoulidis F and Heymach JV: Co-occurring
genomic alterations in non-small-cell lung cancer biology and
therapy. Nat Rev Cancer. 19:495–509. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoneda K, Imanishi N, Ichiki Y and Tanaka
F: Immune checkpoint inhibitors (ICIs) in non-small cell lung
cancer (NSCLC). J UOEH. 40:173–189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie Y, Dang W, Zhang S, Yue W, Yang L,
Zhai X, Yan Q and Lu J: The role of exosomal noncoding RNAs in
cancer. Mol Cancer. 18:372019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu C, Meiners S, Lukas C, Stathopoulos GT
and Chen J: Role of exosomal microRNAs in lung cancer biology and
clinical applications. Cell Prolif. 53:e128282020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williams M, Cheng YY, Blenkiron C and Reid
G: Exploring mechanisms of microRNA downregulation in cancer.
Microrna. 6:2–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng S, Calin GA, Croce CM, Coukos G and
Zhang L: Mechanisms of microRNA deregulation in human cancer. Cell
Cycle. 7:2643–2646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of microRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han F, Huang D, Huang X, Wang W, Yang S
and Chen S: Exosomal microRNA-26b-5p down-regulates ATF2 to enhance
radiosensitivity of lung adenocarcinoma cells. J Cell Mol Med.
24:7730–7742. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang HX, Wang XY, Fei JW, Li FH, Han J and
Qin X: MicroRNA-23B inhibits non-small cell lung cancer
proliferation, invasion and migration via downregulation of RUNX2
and inhibition of Wnt/Β-catenin signaling pathway. J Biol Regul
Homeost Agents. 34:825–835. 2020.PubMed/NCBI
|
|
15
|
Qu Y, Zhu J, Liu J and Qi L: Circular RNA
circ_0079593 indicates a poor prognosis and facilitates cell growth
and invasion by sponging miR-182 and miR-433 in glioma. J Cell
Biochem. 120:18005–18013. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding L and Zhang H: Circ-ATP8A2 promotes
cell proliferation and invasion as a ceRNA to target EGFR by
sponging miR-433 in cervical cancer. Gene. 705:103–108. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan L, You WQ, Sheng NQ, Gong JF, Hu LD,
Tan GW, Chen HQ and Wang ZG: A CREB1/miR-433 reciprocal feedback
loop modulates proliferation and metastasis in colorectal cancer.
Aging (Albany NY). 10:3774–3793. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang T, Jiang K, Zhu X, Zhao G, Wu H,
Deng G and Qiu C: miR-433 inhibits breast cancer cell growth via
the MAPK signaling pathway by targeting Rap1a. Int J Biol Sci.
14:622–632. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Q, Wang Y, Mu Y, Wang X and Fan Q:
miR-433-3p inhibits proliferation and invasion of esophageal
squamous cell carcinoma by targeting GRB2. Cell Physiol Biochem.
46:2187–2196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YJ, Zhang ZF, Fan SH, Zhuang J, Shan
Q, Han XR, Wen X, Li MQ, Hu B, Sun CH, et al: MicroRNA-433 inhibits
oral squamous cell carcinoma cells by targeting FAK. Oncotarget.
8:100227–100241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu N, Liu Z, Zhang W, Li Y, Cao J, Yang H
and Li X: MicroRNA-433 reduces cell proliferation and invasion in
non-small cell lung cancer via directly targeting E2F transcription
factor 3. Mol Med Rep. 18:1155–1164. 2018.PubMed/NCBI
|
|
22
|
Li J, Chen M and Yu B: miR-433 suppresses
tumor progression via Smad2 in non-small cell lung cancer. Pathol
Res Pract. 215:1525912019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Sun Q, Guo J, Wang S, Song G, Liu
W, Liu M and Tang H: GRSF1-mediated MIR-G-1 promotes malignant
behavior and nuclear autophagy by directly upregulating TMED5 and
LMNB1 in cervical cancer cells. Autophagy. 4:668–685. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vishnoi A and Rani S: miRNA biogenesis and
regulation of diseases: An overview. Methods Mol Biol. 1509:1–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sandiford OA, Moore CA, Du J, Boulad M,
Gergues M, Eltouky H and Rameshwar P: Human aging and cancer: Role
of miRNA in tumor microenvironment. Adv Exp Med Biol. 1056:137–152.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu S, Lin Z, Zheng Z, Rao W, Lin Y, Chen
H, Xie Q, Chen Y and Hu Z: Serum exsomal miR-766-3p expression is
associated with poor prognosis of esophageal squamous cell
carcinoma. Cancer Sci. 110:3881–3892. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin H, Zhang L, Zhang C and Liu P:
Exosomal miR-500a-3p promotes cisplatin resistance and stemness via
negatively regulating FBXW7 in gastric cancer. J Cell Mol Med.
24:8930–8941. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weiner-Gorzel K, Dempsey E, Milewska M,
McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A,
Sharpe D, et al: Overexpression of the microRNA miR-433 promotes
resistance to paclitaxel through the induction of cellular
senescence in ovarian cancer cells. Cancer Med. 4:745–758. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weng L, Qiu K, Gao W, Shi C and Shu F:
LncRNA PCGEM1 accelerates non-small cell lung cancer progression
via sponging miR-433-3p to upregulate WTAP. BMC Pulm Med.
20:2132020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santos P and Almeida F: Role of exosomal
miRNAs and the tumor microenvironment in drug resistance. Cells.
9:14502020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bland CL, Byrne-Hoffman CN, Fernandez A,
Rellick SL, Deng W and Klinke DJ 2nd: Exosomes derived from B16F0
melanoma cells alter the transcriptome of cytotoxic T cells that
impacts mitochondrial respiration. FEBS J. 285:1033–1050. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS,
Zhang XS, Cui J, Zeng YX and Li J: Tumor-derived exosomes promote
tumor progression and T-cell dysfunction through the regulation of
enriched exosomal microRNAs in human nasopharyngeal carcinoma.
Oncotarget. 5:5439–5452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Taciak B, Pruszynska I, Kiraga L, Bialasek
M and Krol M: Wnt signaling pathway in development and cancer. J
Physiol Pharmacol. 69:185–196. 2018.PubMed/NCBI
|
|
35
|
Kassumeh S, Weber GR, Nobl M, Priglinger
SG and Ohlmann A: The neuroprotective role of Wnt signaling in the
retina. Neural Regen Res. 16:1524–1528. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang J, Gao W, Liu G, Sheng W, Zhou J,
Dong Q and Dong M: miR-944 suppresses EGF-induced EMT in colorectal
cancer cells by directly targeting GATA6. Onco Targets Ther.
14:2311–2325. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu Z, Zhang Y, Yang Z, Zhu Y, Xie Y, Zhou
F and Cai L: Elevation of miR-302b prevents multiple myeloma cell
growth and bone destruction by blocking DKK1 secretion. Cancer Cell
Int. 21:1872021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie Y, Xue C, Guo S and Yang L:
MicroRNA-520a suppresses pathogenesis and progression of
non-small-cell lung cancer through targeting the RRM2/Wnt axis.
Anal Cell Pathol (Amst). 2021:96524202021.PubMed/NCBI
|
|
40
|
Wang H, Yang Q, Li J, Chen W, Jin X and
Wang Y: MicroRNA-15a-5p inhibits endometrial carcinoma
proliferation, invasion and migration via downregulation of VEGFA
and inhibition of the Wnt/β-catenin signaling pathway. Oncol Lett.
21:3102021. View Article : Google Scholar : PubMed/NCBI
|
